MedTrace Logo

qMOLI- A Qualitative Assessment of Misoprostol or Oxytocin for Labour Induction

NCT04037683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136

Last updated 2022-02-11

No results posted yet for this study

Summary

Q MOLI is an alongside qualitative study, for the 'Misoprostol or Oxytocin for Labour Induction' (MOLI) pragmatic, open-label, randomised controlled trial, comparing a misoprostol/misoprostol regime vs the standard misoprostol/oxytocin induction of labour regime.1000 patients with hypertensive disease in pregnancy will be recruited, over 24 months, in Nagpur, India.

Conditions

  • Pre-Eclampsia

Interventions

DRUG

Misoprostol Oral Tablet

Misoprostol 25mcg orally given 2-hourly

DRUG

Oxytocin

Oxytocin infusion

Sponsors & Collaborators

  • Government Medical College, Nagpur

    collaborator INDUSTRY

  • Gynuity Health Projects

    collaborator OTHER

  • University of Liverpool

    lead OTHER

Principal Investigators

  • Andrew Weeks, Professor · University of Liverpool

  • Kate Lightly, Dr · University of Liverpool

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-18
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04037683 on ClinicalTrials.gov